# The DEBATE Study "DEvelopment of Endotype-based Biomarkers for the Monitoring of Greek pATiEnts With CRSwNP"

> **NCT07663409** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 230 (estimated)

## Conditions studied

- CRSwNP or CRSsNP Patients

## Interventions

- **OTHER:** Not applicable - NIS study

## Key facts

- **NCT ID:** NCT07663409
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-29
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663409, "The DEBATE Study "DEvelopment of Endotype-based Biomarkers for the Monitoring of Greek pATiEnts With CRSwNP"". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07663409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*